QIAGEN has a truly global investor base comprised of more than 335 identified institutional investors distributed around the world, including more than a half in North America, about one-third in Europe and the remaining shares in the Asia-Pacific/Japan region. Members of the Managing Board and the supervisory Board in total held approximately 2.5 % of QIAGEN's outstanding common shares at the end of 2016.
|BlackRock, Inc., United States||21,813||9.45|
|Franklin Resources, Inc., United States||18,757||8.13|
|PRIMECAP Management Company, United States||16,566||7.18|
Status: February 2018